Sema3A levels were significantly higher in moderately ill and overweight patients (<i>p</i> < 0.05, <i>p</i> < 0.01, respectively) and in patients with longer-lasting psoriasis and male patients compared to controls (both <i>p</i> < 0.05). This evidence concerns the gene SEMA3A and psoriasis.